Victoria Simmons

How did you get started in this industry?

I’ve spent the last 20 years working in hematology and oncology sales and marketing. Right out of college, I was recruited for a sales position at one of the largest pharmaceutical companies in the U.S. It was a great fit for me because I enjoy learning about science and I also thrive in a fast-paced environment.

When did you pivot to a smaller biopharmaceutical company?

In 2008, I had an opportunity to join a much smaller company and help work on the launch of a drug for a rare hematologic disease. Working at a smaller company enabled me to work more closely with leadership and inform our marketing and sales strategy. I found that I enjoy working at smaller companies as they are often more dynamic and what you do every day can make a significant impact in the organization.

What do you do at Oncopeptides?

I am one of two Key Customer Marketing leaders in the U.S.

What drew you to Oncopeptides?

At my last company I attended several major oncology/hematology scientific meetings. I attended a couple of Oncopeptides’ data sessions. I found the data presented by Jakob Lindberg, Med Lic, Oncopeptides’ Chief Scientific Officer, compelling and I could also tell immediately how passionate he was to help patients suffering with Multiple Myeloma.

What do you enjoy about your job?

Every day I’m inspired to make a contribution to the lives of people living with Multiple Myeloma. I love sharing information on new therapeutic options with doctors and nurses who are on the front lines of treating patients. I also enjoy learning from our customers and better understanding how we can help support them and their patients. For example, what resources could we develop to help guide them through the journey?

What does a day look like for you?

Every day looks a little different which means I never get bored! I am currently working on developing a peer to peer education platform, a series of disease education videos and I’ve also been quite busy leading advisory boards where we gather insights from leading health care providers.

What do you like about Oncopeptides?

Our culture is very collaborative. I work very closely with many different functions and we are all working towards the same goal – bringing forward a therapy for patients suffering with Multiple Myeloma. There is a lot of transparency across the organization and our leaders are very accessible. I also really appreciate that even though we are preparing for launch we remain very focused on science and data – they are the backbone of the Company.